Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.39
18.69
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Anhui Huaren Health Pharmaceutical Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 5B CNY |
| Gross Margin |
30%
|
| Country | ZA |
| Market Cap | 98.2B Zac |
| Gross Margin |
23%
|
| Country | ZA |
| Market Cap | 31.9B Zac |
| Gross Margin |
23%
|
| Country | BR |
| Market Cap | 44.6B BRL |
| Gross Margin |
30%
|
| Country | US |
| Market Cap | 7.5B USD |
| Gross Margin |
18%
|
| Country | JP |
| Market Cap | 845.2B JPY |
| Gross Margin |
35%
|
| Country | SA |
| Market Cap | 16.8B SAR |
| Gross Margin |
39%
|
| Country | CN |
| Market Cap | 27.3B CNY |
| Gross Margin |
38%
|
| Country | MX |
| Market Cap | 70.6B MXN |
| Gross Margin |
23%
|
| Country | JP |
| Market Cap | 547.7B JPY |
| Gross Margin |
20%
|
| Country | NL |
| Market Cap | 2.9B EUR |
| Gross Margin |
23%
|
Anhui Huaren Health Pharmaceutical Co Ltd
Glance View
Anhui Huaren Health Pharmaceutical Co., Ltd. engages in pharmaceutical distribution. The company is headquartered in Hefei, Anhui and currently employs 5,785 full-time employees. The company went IPO on 2023-03-01. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Anhui Huaren Health Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 30.4%.
You don't have any saved screeners yet
